| 1. |
Huang C, Li R, Shi W, et al. Discovery of the anti-tumor mechanism of calycosin against colorectal cancer by using system pharmacology approach. Med Sci Monit, 2019, 25: 5589-5593.
|
| 2. |
Cheng B, Rong A, Zhou Q, et al. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway. J Exp Clin Cancer Res, 2020, 39(1): 5. doi: 10.1186/s13046-019-1510-7.
|
| 3. |
Pan J, Xu Z, Xu M, et al. Knockdown of forkhead box A1 suppresses the tumorigenesis and progression of human colon cancer cells through regulating the phosphatase and tensin homolog/Akt pathway. J Int Med Res, 2020, 48(12): 300060520971453. doi: 10.1177/0300060520971453.
|
| 4. |
Lazar SB, Pongor L, Li XL, et al. Genome-wide analysis of the FOXA1 transcriptional network identifies novel protein-coding and long noncoding RNA targets in colorectal cancer cells. Mol Cell Biol, 2020, 40(21): e00224-20. doi: 10.1128/MCB.00224-20.
|
| 5. |
Venkatesh V, Nataraj R, Thangaraj GS, et al. Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investig, 2018, 5: 5. doi: 10.21037/sci.2018.02.02.
|
| 6. |
Malki A, ElRuz RA, Gupta I, et al. Molecular mechanisms of colon cancer progression and metastasis: Recent insights and advancements. Int J Mol Sci, 2020, 22(1): 130. doi: 10.3390/ijms22010130.
|
| 7. |
Qiu M, Bao W, Wang J, et al. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer. BMC Cancer, 2014, 14: 78. doi: 10.1186/1471-2407-14-78.
|
| 8. |
周躍. ECM 蛋白 SRPX2 對結腸癌 SW480 細胞生物學行為的影響. 蘭州: 蘭州大學, 2015.
|
| 9. |
Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut, 2017, 66(4): 683-691.
|
| 10. |
Gupta R, Bhatt LK, Johnston TP, et al. Colon cancer stem cells: potential target for the treatment of colorectal cancer. Cancer Biol Ther, 2019, 20(8): 1068-1082.
|
| 11. |
簡小蘭, 曾普華, 李勇敏, 等. 健脾消癌方對結腸癌細胞中 Akt/mTOR 信號通路的影響. 中國實驗方劑學雜志, 2020, 26(7): 73-78.
|
| 12. |
Zhou M, Liu X, Li Z, et al. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. Int J Cancer, 2018, 143(4): 921-930.
|
| 13. |
樊明湖, 陳保華, 車河, 等. miR-186 上調 Dicer1 抑制結腸癌細胞侵襲轉移的分子機制. 現代免疫學, 2020, 40(3): 177-186.
|
| 14. |
張殷, 肖毅. 結腸癌的新輔助治療. 中國普外基礎與臨床雜志, 2020, 27(12): 1480-1484.
|
| 15. |
瞿小祥, 魯小紅. 靶向抑制轉錄因子 FOXA1 對前列腺癌細胞增殖的影響及機制研究. 中國性科學, 2020, 29(5): 1-3.
|
| 16. |
Parolia A, Cieslik M, Chu SC, et al. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. Nature, 2019, 571(7765): 413-418.
|
| 17. |
王凡, 劉偉, 李強, 等. CDKN3 和 FOXA1 mRNA 在直腸癌中的表達關系及意義. 河北醫學, 2021, 27(1): 84-89.
|
| 18. |
冷冰潔, 姜晗, 楊小毅, 等. FOXA1 及 FOXD3 蛋白聯合檢測對胃癌臨床診斷及患者生存率的意義. 現代消化及介入診療, 2020, 25(3): 367-369.
|
| 19. |
鄧振宇, 何傳鳳, 牛占杰. miR-760 在宮頸鱗狀細胞癌組織和細胞中的表達及其對 SiHa 細胞惡性生物學行為的作用. 中國腫瘤生物治療雜志, 2019, 26(10): 1120-1127.
|
| 20. |
孟小琴, 李云峰, 周毅, 等. 過表達 OTUD1 對結腸癌細胞 HCT116 增殖和侵襲的影響及機制研究. 重慶醫科大學學報, 2018, 43(5): 687-691.
|
| 21. |
錢金鋒, 楊其昌, 謝慧君, 等. 乳腺浸潤性導管癌中上皮間質轉化相關蛋白表達與臨床病理特征和預后的關系. 中國普外基礎與臨床雜志, 2015, 22(5): 591-596.
|
| 22. |
Tyagi A, Sharma AK, Damodaran C. A review on Notch signaling and colorectal cancer. Cells, 2020, 9(6): 1549. doi: 10.3390/cells9061549.
|
| 23. |
Li L, Tang P, Li S, et al. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy. Med Oncol, 2017, 34(10): 180. doi: 10.1007/s12032-017-1039-6.
|
| 24. |
Rodrigues C, Joy LR, Sachithanandan SP, et al. Notch signalling in cervical cancer. Exp Cell Res, 2019, 385(2): 111682. doi: 10.1016/j.yexcr.2019.111682.
|
| 25. |
Kontomanolis EN, Kalagasidou S, Pouliliou S, et al. The Notch pathway in breast cancer progression. Sci World J, 2018, 2018: 2415489. doi: 10.1155/2018/2415489.
|
| 26. |
Vinson KE, George DC, Fender AW, et al. The Notch pathway in colorectal cancer. Int J Cancer, 2016, 138(8): 1835-1842.
|